SP

Symbiotec Pharmalab IPO — Grey Market Premium (GMP) Today

NSE + BSE  ·  Mainboard IPO  ·  GMP Tracker
Listed 📋 Mainboard NSE + BSE
+₹185
GMP Today
₹988
Issue Price
₹1173(18.72%)
Est. Listing
₹978.2 ▼ -0.99%
Listed Price
SP Symbiotec Pharmalab Limited IPO Pharmaceuticals & Biotechnology APIs Corticosteroids Nutraceuticals Mainline IPO Fresh + OFS NSE, BSE 988 Upper Price 1,757. The cap price for Symbiotec Pharmalab IPO is ₹988. At the current GMP of +₹185, the estimated listing price is ₹1173 — a 18.72% premium over the issue price. Based on available sessions, grey market activity shows a softening trend. The GMP has ranged between ₹185 and ₹409 since tracking began. Symbiotec Pharmalab is scheduled to list on 01 September 2026. We update GMP every day — bookmark this page to track the latest trend. Note: GMP data is collected from grey market participants for informational purposes only. ForgeUp does not trade in or recommend grey market transactions.
🔍 Data Source: GMP data is collected from grey market dealers and cross-verified across multiple sources before publishing. ForgeUp publishes this for informational purposes only. Rates may vary and are updated daily.
IPO Listed — GMP Tracking Complete
Issue Price (Cap)
₹988
Actual Listed Price
₹978.2
Listing Gain/Loss
▼ -0.99%
Last GMP (Pre-Listing)
+₹185

Symbiotec Pharmalab IPO has listed on NSE + BSE. Track live on NSE or BSE.

GMP History Last 12 sessions

GMP ₹185–₹409Applied for 0.1x → 75.08x
DateTime (IST)GMP (₹)Issue PriceEst. ListingSubscription
01 Sep 202609:00 AM+₹185₹988 ₹1173(18.72%) 5.31x
31 Aug 202611:16 PM+₹200₹988 ₹1188(20.24%) 75.08x
30 Aug 202611:16 PM+₹270₹988 ₹1258(27.33%) 71.26x
29 Aug 202608:06 PM+₹240₹988 ₹1228(24.29%) 75.08x
28 Aug 202610:05 PM+₹340₹988 ₹1328(34.41%) 71.26x
27 Aug 202611:28 PM+₹287₹988 ₹1275(29.05%) 71.26x
26 Aug 202604:01 PM+₹340₹988 ₹1328(34.41%) 3.82x
25 Aug 202611:15 PM+₹409₹988 ₹1397(41.4%) 1.85x
24 Aug 202611:16 PM+₹409₹988 ₹1397(41.4%) 0.1x
23 Aug 202611:16 PM+₹380₹988 ₹1368(38.46%)
22 Aug 202611:16 PM+₹370₹988 ₹1358(37.45%)
21 Aug 202611:16 PM+₹320₹988 ₹1308(32.39%)

What happened to IPOs like this one

The closest matches from 108 past IPOs we have tracked to listing, ranked mainly on how heavily each was applied for. Of these 6, the typical listing was +8.7% and 1 listed below the issue price.

IPOApplied forIssueListed at
Manipal Health Enterprises IPO Main5.12x₹590+11%
Lohia Corp IPO Main7.25x₹425+8.5%
Innovision IPO Main3.46x₹519-9.9%
SEDEMAC Mechatronics IPO Main2.68x₹1,352+13.5%
Amir Chand Jagdish Kumar (Exports) Ltd IPO Main3.41x₹212+0%
Juniper Green Energy IPO Main8.38x₹225+8.9%

These are counts of what happened before, not a forecast. A handful of past IPOs cannot tell you what this one will do, which is why the number of matches is shown rather than hidden.

Frequently Asked Questions

What is Symbiotec Pharmalab IPO GMP today?
Symbiotec Pharmalab IPO GMP today is +₹185. That points to a listing around ₹1173, 18.72% above the issue price. We refresh this hourly.
What is the expected listing price of Symbiotec Pharmalab IPO?
Going by the current grey market premium, Symbiotec Pharmalab IPO would list near ₹1173 against an issue price of ₹988. GMP is a sentiment indicator, not a promise — see our published accuracy record.
What is the lot size and minimum investment for Symbiotec Pharmalab IPO?
One lot of Symbiotec Pharmalab IPO is 15 shares. At the ₹988 issue price that is about ₹14,820 for a single retail application.
When does Symbiotec Pharmalab IPO close and list?
Bidding closes on 27 August 2026 and the shares are expected to list on 01 September 2026. Applications must be in before 5 PM on the closing day.
How has Symbiotec Pharmalab IPO GMP moved?
Across the 12 sessions we have tracked, Symbiotec Pharmalab IPO GMP has ranged between ₹185 and ₹409, and is currently trending down. The full session-by-session history is on this page.
How many times was Symbiotec Pharmalab IPO subscribed?
Symbiotec Pharmalab IPO has been subscribed 5.31 times overall. Figures update through the bidding window.
Did GMP correctly predict the Symbiotec Pharmalab IPO listing price?
GMP pointed to ₹1173 (18.7%). Symbiotec Pharmalab IPO actually listed at ₹978.2 (-1%) — off by 19.7 percentage points. We publish our full GMP accuracy record rather than only the wins.
Where can I check Symbiotec Pharmalab IPO allotment status?
Symbiotec Pharmalab IPO allotment is handled by MUFG Intime India Pvt.. You can check using your PAN or application number on the registrar's site once allotment is finalised.
Is Symbiotec Pharmalab IPO a good investment?
We do not give buy or sell advice. What we can show you is evidence: how heavily this issue is actually being applied for, your realistic chance of getting shares, and what happened to past IPOs that looked like this one. Read those alongside the company's own financials and prospectus, and decide for yourself.

📋 IPO Details

Price Band₹938 – ₹988
Issue Size₹6,094.00 Cr
Lot Size15 shares
Min. Investment₹14,820
Open Date24 Aug 2026
Close Date27 Aug 2026
Listing Date01 Sep 2026
ExchangeNSE + BSE
TypeMainboard
RegistrarMUFG Intime India Pvt.

📊 Subscription Status

Total5.31x

🔔 Daily GMP Alerts

Get GMP updates for all active IPOs every morning on our Telegram channel.

Join Telegram 📖 Full IPO Analysis →
⚠ Disclaimer: GMP is unofficial data from grey market participants. ForgeUp does not trade in or facilitate grey market transactions. This is not investment advice. Consult a SEBI-registered advisor before investing.
🛡️Regulatory Note: The grey market is not regulated by SEBI, NSE, or BSE. GMP data on ForgeUp is from informal sources for informational purposes only. ForgeUp.in does not facilitate or promote any grey market activity. Consult a SEBI-registered investment advisor before investing.
Important Disclaimer: Grey Market Premium (GMP) data on ForgeUp.in is sourced from grey market dealers and informal channels. Published for informational purposes only and does not constitute investment advice. GMP is not guaranteed to reflect actual listing prices. ForgeUp.in is not liable for investment decisions based on GMP data.
Scroll to Top